Omnicell (OMCL) Stock Price, News & Analysis

Company Overview

Omnicell, Inc. provides medication-management technology and related services for health care providers. Its solutions are designed to help hospitals, health systems, retail pharmacies and other care settings manage medication inventory, improve workflow efficiency and support medication adherence.

The company’s offerings include automated medication dispensing systems, central pharmacy automation, medication packaging and adherence solutions, pharmacy inventory management tools, and software for medication-use analytics and workflow management. Omnicell also provides implementation, maintenance, consulting and other support services associated with its technology platforms.

Founded in 1992 and headquartered in Mountain View, California, Omnicell serves customers primarily in the United States, as well as in international markets. Its products are used across hospitals, health-system pharmacies, long-term care facilities, specialty pharmacies and other health care environments.

Key Stats

• Today's Range: $33.41 to $33.96
• 50-Day Range: $32.23 to $43.05
• 52-Week Range: $29.06 to $55.00
• Volume: 344,489 shs
• Average Volume: 490,853 shs
• Market Capitalization: $1.53 billion
• P/E Ratio: 40.00
• Dividend Yield: N/A
• Price Target: $57.86
• Consensus Rating: Moderate Buy

Omnicell Stock Analysis - MarketRank™

Omnicell scored higher than 84% of companies evaluated by MarketBeat, and ranked 82nd out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Omnicell has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 7 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

Omnicell has a consensus price target of $57.86, representing about 72.2% upside from its current price of $33.60.

Amount of Analyst Coverage

Omnicell has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: -26.95%

Earnings Growth

Earnings for Omnicell are expected to decrease by -26.95% in the coming year, from $1.41 to $1.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Omnicell is 40.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Omnicell is 40.00, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.01.

Price to Earnings Growth Ratio

Omnicell has a PEG Ratio of 0.84. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Omnicell has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.45% of the float of Omnicell has been sold short.

Short Interest Ratio / Days to Cover

Omnicell has a short interest ratio ("days to cover") of 5.48.

Change versus previous month

Short interest in Omnicell has recently decreased by 0.08%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Omnicell does not currently pay a dividend.

Dividend Growth

Omnicell does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Omnicell has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Omnicell this week, compared to 4 articles on an average week.

Search Interest

3 people have searched for OMCL on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

MarketBeat Follows

7 people have added Omnicell to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Omnicell insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.92% of the stock of Omnicell is held by insiders.

Percentage Held by Institutions

97.70% of the stock of Omnicell is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 10/05/2026
• Next Earnings (Estimated): 10/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:OMCL
• CIK: 926326
• Web: www.omnicell.com
• Phone: (877) 415-9990
• Fax: 847-596-3402
• Employees: 3,580
• Year Founded: 1992

Price Target and Rating

• Average Price Target for Omnicell: $57.86
• High Price Target: $70.00
• Low Price Target: $45.00
• Potential Upside/Downside: +72.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.78
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.84
• Trailing P/E Ratio: 40.00
• Forward P/E Ratio: 23.83
• P/E Growth: 0.84
• Net Income: $2.05 million
• Net Margins: 3.13%
• Pretax Margin: 4.90%
• Return on Equity: 5.66%
• Return on Assets: 3.57%

Debt

• Debt-to-Equity Ratio: 0.13
• Current Ratio: 1.64
• Quick Ratio: 1.43

Sales & Book Value

• Annual Sales: $1.18 billion
• Price / Sales: 1.29
• Cash Flow: $2.77 per share
• Price / Cash Flow: 12.15
• Book Value: $27.45 per share
• Price / Book: 1.22

Miscellaneous

• Outstanding Shares: 45,480,000
• Free Float: 44,151,000
• Market Cap: $1.53 billion
• Optionable: Optionable
• Beta: 0.98